(Q80670463)
Statements
The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups (English)
Claus Roehrborn
Janet van Adelsberg
Peter Gann
Amy T Ko
Jan-Erik Damber
Christopher Logothetis
Michael Marberger
Bernd J Schmitz-Drager
Andrea Tubaro